Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amoxicillin sodium + sulbactam sodium
- Development stage
- Unknown
- Lead developer
- Sichuan Pharmaceutical
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular
01
Overview
Amoxicillin sodium + sulbactam sodium is a combination antibiotic drug consisting of the broad-spectrum beta-lactam amoxicillin and the beta-lactamase inhibitor sulbactam. Amoxicillin acts by binding to and inhibiting penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis. Sulbactam protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending its spectrum of activity. This combination is administered via injection and is indicated for various infectious diseases caused by resistant, enzyme-producing bacteria, including upper and lower respiratory tract infections and urogenital system infections. It was developed and is manufactured by Sichuan Proud Era Pharmaceutical (Sichuan Pharmaceutical Inc.).
- Other names
- amoxicillin sodium + sulbactam sodiumamoxicillin/sulbactamamoxicillin sodium + sulbactam sodium for injection
02
Targets
Class A BL (Class A beta-lactamase)PBP (Penicillin-binding protein family)
Beyond the preview
Go deeper on amoxicillin sodium + sulbactam sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amoxicillin sodium + sulbactam sodium.